Literature DB >> 3495594

B cell stimulatory factor-1 (interleukin 4) prepares resting murine B cells to secrete IgG1 upon subsequent stimulation with bacterial lipopolysaccharide.

C M Snapper, W E Paul.   

Abstract

B cell stimulatory factor-1 (BSF-1)/interleukin 4 markedly enhances IgG1 and IgE secretion by B cells stimulated with bacterial lipopolysaccharide (LPS). We show that preincubation of resting B cells with BSF-1 alone prepares them to secrete IgG1, but not IgE, on subsequent stimulation with LPS. The ability of BSF-1 preincubation to increase overall viable cell yield on the subsequent addition of LPS only partially accounts for this enhancement. The degree of enhancement is dependent on the duration of preincubation, up to at least 48 hr. BSF-1 exerts this effect on resting B cells which have been selected for absence of surface IgG and in the presence of the reversible DNA synthesis inhibitor, hydroxyurea. BSF-1 can act to significantly enhance the IgG1 response when added for 48-hr periods before, at the same time as, or after the addition of LPS. These results suggest strongly that the mode of action of BSF-1 in preparing for the secretion of IgG1 is independent of that of LPS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495594

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Contribution of mast cells to the T helper 2 response induced by simultaneous subcutaneous and oral immunization.

Authors:  I Aoki; S Itoh; S Yokota; S Tanaka; N Ishii; K Okuda; M Minami; D M Klinman
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Structure and expression of mouse germline immunoglobulin gamma 3 heavy chain transcripts induced by the mitogen lipopolysaccharide.

Authors:  S Gerondakis; C Gaff; D J Goodman; R J Grumont
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  A cautionary note concerning the possibility that transforming growth factor-beta is a switch factor that acts on primary B cells to initiate IgA expression.

Authors:  J J Cebra; A George; R L Kerlin
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Interleukin 4 induces membrane Thy-1 expression on normal murine B cells.

Authors:  C M Snapper; P V Hornbeck; U Atasoy; G M Pereira; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Structure and expression of murine germ-line immunoglobulin epsilon heavy chain transcripts induced by interleukin 4.

Authors:  S Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model.

Authors:  N M O'Brien-Simpson; R A Paolini; E C Reynolds
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells.

Authors:  B J Rollins; J S Pober
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

8.  Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice.

Authors:  M Schultz; S H Clarke; L W Arnold; R B Sartor; S L Tonkonogy
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

9.  In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.

Authors:  T Ohira; Y Ohe; Y Heike; E R Podack; K J Olsen; K Nishio; M Nishio; Y Miyahara; Y Funayama; H Ogasawara
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Activation-induced deaminase-mediated class switch recombination is blocked by anti-IgM signaling in a phosphatidylinositol 3-kinase-dependent fashion.

Authors:  Lynn M Heltemes-Harris; Patricia J Gearhart; Paritosh Ghosh; Dan L Longo
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.